v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The following table summarizes stock option activity for the year ended December 31, 2025:

 

 

Number of
Stock Options
Outstanding

 

 

Weighted
Average
Exercise Price
per Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Balance at January 1, 2025

 

 

4,499,702

 

 

$

17.19

 

 

 

8.7

 

 

$

24,867

 

Options granted

 

 

2,432,800

 

 

 

23.77

 

 

 

 

 

 

42,437

 

Options exercised

 

 

(627,148

)

 

 

12.60

 

 

 

 

 

 

14,919

 

Options forfeited

 

 

(314,011

)

 

 

21.07

 

 

 

 

 

 

1,690

 

Balance at December 31, 2025

 

 

5,991,343

 

 

$

20.14

 

 

 

8.3

 

 

$

127,547

 

Exercisable options at December 31, 2025

 

 

2,336,600

 

 

$

17.01

 

 

 

7.6

 

 

$

57,823

 

Unvested options at December 31, 2025

 

 

3,654,743

 

 

$

22.14

 

 

 

8.8

 

 

$

69,724

 

Schedule of Grant-Date Fair Value of Stock Options Issued, Presented on a Weighted Average Basis

The table below summarizes the assumptions used to determine the grant-date fair value of stock options issued, presented on a weighted average basis:

 

 

Year Ended
December 31,

 

 

 

2025

 

 

2024

 

Risk-free interest rate

 

 

4.2

%

 

 

4.2

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

Expected volatility

 

 

91.5

%

 

 

92.6

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

Schedule of Stock Based Compensation Expense

The following table provides a summary of stock-based compensation expense:

 

 

 

Year Ended
December 31,

 

 

2025

 

 

2024

 

Research and development

 

$

10,090

 

 

$

5,576

 

General and administrative

 

 

12,703

 

 

 

7,318

 

Total stock-based compensation expense

 

$

22,793

 

 

$

12,894